The FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications
CN Bio, a leading developer of single- and multi-organ-on-chip microphysiological systems (MPS) that...
Genes discovered that regulate level of harmful fatty substances in liver
As many as one in every three Norwegians could hav...
Auto-aggressive immune cells cause liver immune pathology in non-alcoholic steatohepatitis
Non-alcoholic steatohepatitis (NASH), often called...
